Aesthetic Medical International Holdings Group's EBIT is $-60M, below the Healthcare sector average of $23B.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2023
Trailing 12 months ending Dec 31, 2023
As of the most recent data (December 2023), AIH shows a EBIT of $-60M. That compares with $-73M in the prior-year period — up 17.9% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AIH's EBIT is now $-60M (was $-73M) — a 17.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Aesthetic Medical International Holdings Group is outperforming or lagging.
The Healthcare sector average EBIT is about $23B. Aesthetic Medical International Holdings Group is at $-60M, which is lower that average. That is roughly 100.3% below the sector mean. Use the comparison chart on this page to see how AIH stacks up against individual peers as well.
Tracking AIH's ebit over time shows whether Aesthetic Medical International Holdings Group is scaling, shrinking, or reshaping that part of the business. The current reading is $-60M That compares with $-73M in the prior-year period — up 17.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Aesthetic Medical International Holdings Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-60M) with ownership activity and broader fundamentals.